Invia ad un amico
RSS
google +
Versione stampabile

Notizie (Dialogo e collaborazione)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

[EPHA Analysis] Health in the 2014 Country Specific Recommendations    epha.org

17 July 2014 - On 2 June the European Commission published the 2014 round of Country Specific Recommendations (CSRs). This year, 15 member states have received recommendations related to health. Belo[...]

Scientific guideline: Concept paper on the need for revision of the guideline on clinical investigation of medicinal products for the prophylaxis of venous thromboembolic risk in non- surgical patients, draft: consultation open    europa.eu

A key element in the benefit risk assessment of drugs used for prophylaxis of venous thromboembolism (VTE) is balancing their antithrombotic effect versus the risk of bleeding[...]

Peer Review in Poland: The Active Ageing Index and its extension to the regional level    europa.eu

The Active Ageing Index (AAI) focuses on the untapped potential of older people, measuring their independence and participation in paid employment and social activities. In 2013, in a unique move, Po[...]

Peer Review in Slovenia: Long-term care – the problem of sustainable financing    europa.eu

Like most of Europe, Slovenia faces rapid population ageing. This places huge strain on long-term care (LTC) in particular, and the country has no unified system for providing it. To address this def[...]

Peer Review in Austria: The political adequacy of quantitative impact assessment in the social field by means of micro-simulation models    europa.eu

Since July 2013, the SORESI micro-simulation model has been helping Austria's policy-makers assess the likely impact of proposed policy reforms on the country's most vulnerable social groups. This Pe[...]

Peer Review in Belgium: Children First – pilot local consultation platforms on child poverty    europa.eu

In May 2014, the Belgian government embarked on funding a year-long pilot project of local `consultation platforms', intended to raise awareness of child poverty, provide parents with information abo[...]

Guide on methodological standards in pharmacoepidemiology revised to include pharmacogenetic studies    europa.eu

The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), coordinated by the European Medicines Agency, has revised its guide on methodological standards in pharmacoepi[...]

Workshop on characterisation of new clotting factor concentrates: new report available    edqm.eu

11 July 2014 Workshop on characterisation of new clotting factor concentrates (FVIII, FIX): new report available A workshop on Characterisation of new clotting factor concentrates (FVIII, FIX) with r[...]

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 July 2014    europa.eu

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) concluded two safety reviews and gave a recommendation as part of a regular benefit-risk assessment review of [...]

Pharmacopoeial Discussion Group achievements July 2014    edqm.eu

07 July 2014 Pharmacopoeial Discussion Group Achievements The meeting of the Pharmacopoeial Discussion Group (PDG) [European Pharmacopoeia (Ph. Eur.), Japanese Pharmacopoeia (JP), and the United Stat[...]

Peer Review on Youth Guarantee, Helsinki, Finland, 18-19 September 2014    europa.eu

Over 30 delegates from different Member States and International bodies will attend a two-day Peer Review on the different experience and practices across EU countries regarding to specific aspects o[...]

Peer Review on Counterfactual Impact Evaluation, Prague, Czech Republic, 6-7 October 2014    europa.eu

Peer Review on counterfactual impact evaluation, Prague, Czech Republic, 6-7 October 2014[...]

Peer Review on Flexicurity, Copenhagen, Denmark, 13-14 November 2014    europa.eu

Peer Review on Flexicurity, Copenhagen, Denmark, 13-14 November 2014[...]

EDQM celebrates 50th Anniversary of the European Pharmacopoeia with inauguration of an exhibition    edqm.eu

02 July 2014 EDQM celebrates 50th Anniversary of the European Pharmacopoeia with inauguration of an exhibition To celebrate the 50th Anniversary of the adoption of the Convention on the elaboration o[...]

Committee of the PACE reassert total ban on any form of commercialisation of human organs    edqm.eu

01 July 2014 Committee of the PACE reassert total ban on any form of commercialisation of human organs On 24 June 2014, the Social Affairs Committee of the Parliamentary Assembly of the Council of Eu[...]

Scientific guideline: Draft guideline on the clinical investigation of medicinal products to prevent development/slow progression of chronic renal insufficiency, draft: consultation open    europa.eu

The aim of this guideline is to provide guidance on the clinical development of compounds used to prevent the development and to slow the progression of chronic renal insufficiency.[...]

Scientific guideline: Draft reflection paper on classification of advanced-therapy medicinal products, draft: consultation open    europa.eu

This reflection paper has been updated to reflect the current thinking of the Committee on Advanced Therapies (CAT) on substantial manipulation and non-homologous use. Additional changes have been im[...]

Scientific guideline: Questions and answers on benzalkonium chloride in the context of the revision of the guideline on excipients in the label and package leaflet of medicinal products for human use, draft: consultation open    europa.eu

Following the European Commission decision to revise the annex of the guideline on excipients in the label and package leaflet of medicinal products for human use, a multidisciplinary group of expert[...]

149th Session of the European Pharmacopoeia Commission    edqm.eu

26 June 2014 149th Session of the European Pharmacopoeia Commission During its 149th session, the European Pharmacopoeia Commission adopted six new texts for inclusion in the European Pharmacopoeia, [...]

Scientific guideline: Concept paper on qualification and reporting of physiologically-based pharmacokinetic (PBPK) modelling and analyses, draft: consultation open    europa.eu

This Concept Paper proposes the drafting of a guideline on how to report the results from and performance of a Physiologically-based Pharmacokinetic (PBPK) analysis.[...]

Training to improve HIV Prevention in Europe    aidsactioneurope.org

Quality Action is a unique EU- wide project that aims to increase the effectiveness of HIV prevention in Europe. It promotes quality assurance (QA) and quality improvement (QI) tools that are adapted[...]

149th Session of the European Pharmacopoeia Commission    edqm.eu

26 June 2014 149th Session of the European Pharmacopoeia Commission During its 149th session, the European Pharmacopoeia Commission adopted six new texts for inclusion in the European Pharmacopoeia, [...]

TGA joins EDQM’s CEP assessment process    edqm.eu

26 June 2014 TGA joins EDQM's CEP assessment process The European Directorate for the Quality of Medicines and HealthCare (EDQM) and the Australian Therapeutic Goods Administration (TGA) are strength[...]

International scientific workshop: Risk assessment considerations for RNAi-based GM plants    europa.eu

Published on: More than 100 scientific experts attended EFSA's international workshop on RNAi (ribonucleic acid interference) in genetically modified (GM) plants in Brussels. The two-day event on 4-5[...]

EU project completes largest study of European building stock    europa.eu

The European Union is working towards ambitious targets for the reduction of energy consumption of buildings in Europe. This includes a bold renovation target which seeks to transform existing buildi[...]

Update to the European Pharmacopoeia Work Programme    edqm.eu

18 June 2014 Update to the European Pharmacopoeia Work Programme The work programme of the European Pharmacopoeia was recently updated (March 2014) with the texts to be revised, new texts to be elabo[...]

Official medicines control laboratories : evolution of its role in Europe in surveillance and control of medicines on the market    edqm.eu

05 June 2014 Official medicines control laboratories : evolution of its role in Europe in surveillance and control of medicines on the market This year's Annual Meeting of the General European OMCL N[...]

EDQM Published Annual Report for the year 2013    edqm.eu

18 June 2014 EDQM Publishes Annual Report for the year 2013 The EDQM has just published its 2013 Annual Report. The report is an opportunity to review the different activities of the past year and re[...]

Outcome report on first European collaboration between regulators and HTA organisations: improving the contribution of regulatory assessment reports to health technology assessment    europa.eu

The report of an initiative undertaken jointly by the European Medicines Agency (EMA) and the European network for Health Technology Assessment (EUnetHTA) to make regulators' reports about scientific[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.